Your English writing platform
Discover LudwigExact(4)
Systemic sclerosis/scleroderma.
Few trials evaluating the safety and efficacy of MSCs in Sjögren's syndrome and systemic sclerosis/scleroderma are ongoing.
Subsequent label revisions have included the addition of patients with PAH related to systemic sclerosis/scleroderma (year 2000) and all patients with PAH regardless of etiology to improve exercise capacity (year 2011).
Patients with systemic sclerosis/scleroderma, a rare connective tissue disease that causes skin and internal organ fibrosis especially in the lungs, vascular disease, and autoantibody production, undergo PFTs to screen for the development and progression of lung disease.
Similar(56)
Systemic Risk.
Systemic risk.
The problems are systemic.
It's systemic.
Chronic graft-versus-host disease (cGvHD) and systemic sclerosis (scleroderma [SSc]) share clinical characteristics, including skin and internal organ fibrosis.
Systemic sclerosis (scleroderma, SSc) is a complex autoimmune disease in which excessive accumulation of extracellular matrix (ECM) in the skin and internal organs is a major pathological finding.
Dear Editor, Systemic sclerosis (scleroderma, SSc) is a chronic disease of connective tissues, and is clinically characterized by persistent fibrosis in the skin as well as in a variety of organs (Katsumoto et al., 2011).
More suggestions(1)
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com